Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS)
CNY 29.78
(0.51%)
CNY 29.78
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.54 Billion | 2.62 Billion | 1.89 Billion | 1.78 Billion | 2.14 Billion | 1.7 Billion |
| Net Income | 2.82 Billion | 2.17 Billion | 1.71 Billion | 1.27 Billion | 1.62 Billion | 1.68 Billion |
| Depreciation & Amortization | 304.1 Million | 308.8 Million | 293.8 Million | 280.95 Million | 232.49 Million | 175.5 Million |
| Deferred income taxes | 3.94 Million | 4.71 Million | 6.96 Million | 5.62 Million | 22.15 Million | 33.6 Million |
| Stock-based compensation | 13.32 Million | 4.63 Million | - | - | - | - |
| Change in working capital | 409.24 Million | 131.66 Million | -1.94 Million | 170.85 Million | 281.54 Million | -204.75 Million |
| Other non-cash items | 213.49 Million | -711.46 Thousand | -114.74 Million | 52.66 Million | 10.65 Million | 50.53 Million |
| Investing Cash Flow | -476.34 Million | -1.5 Billion | -673.29 Million | -1.48 Billion | -444.45 Million | -263.14 Million |
| Investments in PPE | -301.64 Million | -243.65 Million | -248.31 Million | -429.62 Million | -546.43 Million | -668.05 Million |
| Acquisitions | 7.97 Million | 52.81 Million | 50.79 Million | 35.5 Million | 547.11 Million | - |
| Investment purchases | -4.83 Billion | -6.18 Billion | -4.82 Billion | -1.76 Billion | -681 Million | -1.37 Billion |
| Sales/Maturities of investments | 4.65 Billion | 4.86 Billion | 4.4 Billion | 680.6 Million | 782.3 Million | 1.76 Billion |
| Other Investing Activities | 1.00 | 0.90 | -49.99 Million | 1.54 Million | -546.43 Million | 14.01 Million |
| Financing Cash Flow | -150.68 Million | -117.58 Million | -361.19 Million | 373.79 Million | -1 Billion | -810.71 Million |
| Debt repayment | -695.43 Million | -7.51 Million | -849.70 | -172.51 | -538.56 | -22.57 Thousand |
| Dividends payments | -823.18 Million | -604.02 Million | -399.71 Million | -1 Billion | -1 Billion | -810.68 Million |
| Common Stock Repurchased | -35.66 Million | - | - | 22.4 Million | - | - |
| Common Stock Issuance | - | - | - | -22.4 Million | - | - |
| Other Financing Activities | 2.12 Million | 495.39 Million | 48.18 Million | 1.38 Billion | -2.95 Million | -953.84 Thousand |
| Accounts receivables | 22.81 Million | -713.7 Million | -181.18 Million | 15.24 Million | 28.71 Million | -368.12 Million |
| Accounts payables | 476.51 Million | 856.54 Million | 269.43 Million | 89.93 Million | 250.98 Million | 205.51 Million |
| Inventory | -98.6 Million | -15.88 Million | -97.16 Million | 60.04 Million | -20.31 Million | -75.74 Million |
| Other working capital | 8.51 Million | 4.71 Million | 6.96 Million | 5.62 Million | 22.15 Million | -129 Million |
| Cash at beginning of period | 4.81 Billion | 3.81 Billion | 2.95 Billion | 2.28 Billion | 1.58 Billion | 951.61 Million |
| Cash at end of period | 7.73 Billion | 4.81 Billion | 3.81 Billion | 2.95 Billion | 2.28 Billion | 1.58 Billion |
| Capital Expenditure | -301.64 Million | -243.65 Million | -248.31 Million | -429.62 Million | -546.43 Million | -668.05 Million |
| Effect of forex changes on cash | 1.00 | - | 0.71 | 0.43 | -0.31 | - |
| Net cash flow / Change in cash | 2.91 Billion | 999.94 Million | 859.83 Million | 674.34 Million | 697.91 Million | 635.29 Million |
| Free Cash Flow | 3.24 Billion | 2.37 Billion | 1.64 Billion | 1.35 Billion | 1.6 Billion | 1.04 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 564.52 Million | 493.04 Million | 845.26 Million | 2.82 Billion | 878.62 Million | 604.31 Million |
| Depreciation & Amortization | - | 76.21 Million | 76.21 Million | 304.1 Million | 74.55 Million | -151.85 Million |
| Deferred income taxes | - | - | - | 3.94 Million | 53.94 Million | 737.53 Million |
| Stock-based compensation | - | 7.03 Million | - | 13.32 Million | 13.32 Million | -6 Million |
| Change in working capital | - | 689.65 Million | - | 409.24 Million | -67.26 Million | -579.67 Million |
| Other non-cash items | -377.35 Million | -187.29 Million | 509.34 Million | 213.49 Million | -342.14 Million | 81.76 Million |
| Investing Cash Flow | -20.99 Million | -3.72 Billion | 1.64 Billion | -476.34 Million | -807.46 Million | -976.01 Million |
| Investments in PPE | -36.58 Million | -21.28 Million | -86.34 Million | -301.64 Million | -63.48 Million | -109.51 Million |
| Acquisitions | 656 Thousand | 83.12 Thousand | -1.74 Billion | 7.97 Million | 302.77 Thousand | 869.02 Thousand |
| Investment purchases | -270 Million | -4.03 Billion | -369 Million | -4.83 Billion | -1.43 Billion | -2.21 Billion |
| Sales/Maturities of investments | 284.93 Million | 340 Million | 2.1 Billion | 4.65 Billion | 695.61 Million | 1.34 Billion |
| Other Investing Activities | 656 Thousand | -3.69 Billion | 1.74 Billion | 1.00 | 1.00 | 1.00 |
| Financing Cash Flow | -104.48 Million | -1.42 Billion | 651.74 Million | -150.68 Million | 258.39 Million | -252.61 Million |
| Debt repayment | -80.18 Million | -245.22 Million | -667.37 Million | -695.43 Million | -293.78 Million | -1.86 Million |
| Dividends payments | -12.04 Million | -1.19 Billion | -8.34 Million | -811.11 Million | -811.11 Million | -495.87 Million |
| Common Stock Repurchased | 10.03 Million | -10.03 Million | - | -35.66 Million | -35.66 Million | -6.85 Million |
| Common Stock Issuance | - | - | - | - | - | 6.85 Million |
| Other Financing Activities | -12.25 Million | 27.2 Million | -15.63 Million | 2.12 Million | 812.85 Million | 245.12 Million |
| Accounts receivables | - | 893.16 Million | - | 22.81 Million | 22.81 Million | -719.37 Million |
| Accounts payables | - | - | - | 476.51 Million | - | 3.19 Million |
| Inventory | - | -207.56 Million | - | -98.6 Million | -98.6 Million | 139.69 Million |
| Other working capital | - | 4.04 Million | - | 8.51 Million | 8.51 Million | -3.19 Million |
| Cash at beginning of period | 6.47 Billion | 11.39 Billion | 7.73 Billion | 4.81 Billion | 7.67 Billion | 8.24 Billion |
| Cash at end of period | 6.52 Billion | 6.47 Billion | 11.39 Billion | 7.73 Billion | 7.73 Billion | 7.67 Billion |
| Capital Expenditure | -36.58 Million | -21.28 Million | -86.34 Million | -301.64 Million | -63.48 Million | -109.51 Million |
| Effect of forex changes on cash | - | - | 1.00 | 1.00 | 1.00 | -24.96 Million |
| Net cash flow / Change in cash | 46.74 Million | -4.91 Billion | 3.65 Billion | 2.91 Billion | 61.95 Million | -567.51 Million |
| Free Cash Flow | 150.58 Million | 208.24 Million | 1.26 Billion | 3.24 Billion | 547.54 Million | 576.56 Million |
TTE
HOYFF
SCC
ASTE
CMIL
HACBY